BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23948009)

  • 1. Nonprescribed hormone use and self-performed surgeries: "do-it-yourself" transitions in transgender communities in Ontario, Canada.
    Rotondi NK; Bauer GR; Scanlon K; Kaay M; Travers R; Travers A
    Am J Public Health; 2013 Oct; 103(10):1830-6. PubMed ID: 23948009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High heterogeneity of HIV-related sexual risk among transgender people in Ontario, Canada: a province-wide respondent-driven sampling survey.
    Bauer GR; Travers R; Scanlon K; Coleman TA
    BMC Public Health; 2012 Apr; 12():292. PubMed ID: 22520027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervenable factors associated with suicide risk in transgender persons: a respondent driven sampling study in Ontario, Canada.
    Bauer GR; Scheim AI; Pyne J; Travers R; Hammond R
    BMC Public Health; 2015 Jun; 15():525. PubMed ID: 26032733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reported emergency department avoidance, use, and experiences of transgender persons in Ontario, Canada: results from a respondent-driven sampling survey.
    Bauer GR; Scheim AI; Deutsch MB; Massarella C
    Ann Emerg Med; 2014 Jun; 63(6):713-20.e1. PubMed ID: 24184160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences of and barriers to transition-related healthcare among Korean transgender adults: focus on gender identity disorder diagnosis, hormone therapy, and sex reassignment surgery.
    Lee H; Park J; Choi B; Yi H; Kim SS
    Epidemiol Health; 2018; 40():e2018005. PubMed ID: 29514430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and gender diversity among transgender persons in Ontario, Canada: results from a respondent-driven sampling survey.
    Scheim AI; Bauer GR
    J Sex Res; 2015; 52(1):1-14. PubMed ID: 24750105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans people's experiences with assisted reproduction services: a qualitative study.
    James-Abra S; Tarasoff LA; Green D; Epstein R; Anderson S; Marvel S; Steele LS; Ross LE
    Hum Reprod; 2015 Jun; 30(6):1365-74. PubMed ID: 25908658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug use among transgender people in Ontario, Canada: Disparities and associations with social exclusion.
    Scheim AI; Bauer GR; Shokoohi M
    Addict Behav; 2017 Sep; 72():151-158. PubMed ID: 28411424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care availability, quality, and unmet need: a comparison of transgender and cisgender residents of Ontario, Canada.
    Giblon R; Bauer GR
    BMC Health Serv Res; 2017 Apr; 17(1):283. PubMed ID: 28420361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LGBT Identity, Untreated Depression, and Unmet Need for Mental Health Services by Sexual Minority Women and Trans-Identified People.
    Steele LS; Daley A; Curling D; Gibson MF; Green DC; Williams CC; Ross LE
    J Womens Health (Larchmt); 2017 Feb; 26(2):116-127. PubMed ID: 27898255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
    Rowniak S; Bolt L; Sharifi C
    JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1826-1854. PubMed ID: 31021971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Prescribed Hormone Use and Barriers to Care for Transgender Women in San Francisco.
    de Haan G; Santos GM; Arayasirikul S; Raymond HF
    LGBT Health; 2015 Dec; 2(4):313-23. PubMed ID: 26788772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Impacting Transgender Patients' Discomfort with Their Family Physicians: A Respondent-Driven Sampling Survey.
    Bauer GR; Zong X; Scheim AI; Hammond R; Thind A
    PLoS One; 2015; 10(12):e0145046. PubMed ID: 26678997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic Differences by Survey Mode in a Respondent-Driven Sampling Study of Transgender People in Ontario, Canada.
    Scheim AI; Bauer GR; Coleman TA
    LGBT Health; 2016 Oct; 3(5):391-5. PubMed ID: 26684541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Correlates of Nonprescription Hormone Use Among Trans Women in São Paulo, Brazil.
    Costa MCB; McFarland W; Wilson EC; Xie H; Arayasirikul S; Moura FD; Veras MASM
    LGBT Health; 2021; 8(2):162-166. PubMed ID: 33439757
    [No Abstract]   [Full Text] [Related]  

  • 16. Sexual Inactivity Among Transfeminine Persons: A Canadian Respondent-Driven Sampling Survey.
    Scheim AI; Bauer GR
    J Sex Res; 2019 Feb; 56(2):264-271. PubMed ID: 29190148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonprescribed Sex Hormone Use Among Trans Women: The Complex Interplay of Public Policies, Social Context, and Discrimination.
    Maschião LF; Bastos FI; Wilson E; McFarland W; Turner C; Pestana T; Veras MA
    Transgend Health; 2020 Dec; 5(4):205-215. PubMed ID: 33644312
    [No Abstract]   [Full Text] [Related]  

  • 18. A potential role for the dermatologist in the physical transformation of transgender people: A survey of attitudes and practices within the transgender community.
    Ginsberg BA; Calderon M; Seminara NM; Day D
    J Am Acad Dermatol; 2016 Feb; 74(2):303-8. PubMed ID: 26669479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Wouldn't it be easier if you continued to be a guy?' - a qualitative interview study of transsexual persons' experiences of encounters with healthcare professionals.
    von Vogelsang AC; Milton C; Ericsson I; Strömberg L
    J Clin Nurs; 2016 Dec; 25(23-24):3577-3588. PubMed ID: 27264209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
    Arnold JD; Sarkodie EP; Coleman ME; Goldstein DA
    J Sex Med; 2016 Nov; 13(11):1773-1777. PubMed ID: 27671969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.